Literature DB >> 12821622

Canadian consensus guidelines for the care of HIV-positive pregnant women: putting recommendations into practice.

David R Burdge1, Deborah M Money, John C Forbes, Sharon L Walmsley, Fiona M Smaill, Marc Boucher, Lindy M Samson, Marc Steben.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12821622      PMCID： PMC161614     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  10 in total

1.  Prevention of perinatal transmission of HIV infection.

Authors:  J L Robinson; B E Lee
Journal:  CMAJ       Date:  2000-10-03       Impact factor: 8.262

2.  Aiming for zero: preventing mother-to-child transmission of HIV.

Authors:  Kathleen Steel O'Connor; Susan E MacDonald
Journal:  CMAJ       Date:  2002-04-02       Impact factor: 8.262

3.  Failure to prevent perinatal HIV infection.

Authors:  Ari Bitnun; Susan M King; Cheryl Arneson; Stanley E Read
Journal:  CMAJ       Date:  2002-04-02       Impact factor: 8.262

4.  Canadian consensus guidelines for the management of pregnancy, labour and delivery and for postpartum care in HIV-positive pregnant women and their offspring (summary of 2002 guidelines).

Authors:  David R Burdge; Deborah M Money; John C Forbes; Sharon L Walmsley; Fiona M Smaill; Marc Boucher; Lindy M Samson; Marc Steben
Journal:  CMAJ       Date:  2003-06-24       Impact factor: 8.262

Review 5.  Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel.

Authors:  C C Carpenter; D A Cooper; M A Fischl; J M Gatell; B G Gazzard; S M Hammer; M S Hirsch; D M Jacobsen; D A Katzenstein; J S Montaner; D D Richman; M S Saag; M Schechter; R T Schooley; M A Thompson; S Vella; P G Yeni; P A Volberding
Journal:  JAMA       Date:  2000-01-19       Impact factor: 56.272

6.  Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy.

Authors:  E Martínez; J L Blanco; J A Arnaiz; J B Pérez-Cuevas; A Mocroft; A Cruceta; M A Marcos; A Milinkovic; M A García-Viejo; J Mallolas; X Carné; A Phillips; J M Gatell
Journal:  AIDS       Date:  2001-07-06       Impact factor: 4.177

Review 7.  Guidelines for antiretroviral therapy for HIV infection. Canadian HIV Trials Network Antiretroviral Working Group.

Authors:  A R Rachlis; D P Zarowny
Journal:  CMAJ       Date:  1998-02-24       Impact factor: 8.262

8.  Safety of the maternal-infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 Study.

Authors:  R S Sperling; D E Shapiro; G D McSherry; P Britto; B E Cunningham; M Culnane; R W Coombs; G Scott; R B Van Dyke; W T Shearer; E Jimenez; C Diaz; D D Harrison; J F Delfraissy
Journal:  AIDS       Date:  1998-10-01       Impact factor: 4.177

9.  Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidovudine in human immunodeficiency virus type 1-infected pregnant women and their offspring.

Authors:  J Moodley; D Moodley; K Pillay; H Coovadia; J Saba; R van Leeuwen; C Goodwin; P R Harrigan; K H Moore; C Stone; R Plumb; M A Johnson
Journal:  J Infect Dis       Date:  1998-11       Impact factor: 5.226

10.  Pharmacokinetics and tolerance of zidovudine in preterm infants.

Authors:  Edmund V Capparelli; Mark Mirochnick; Wayne M Dankner; Suzette Blanchard; Lynne Mofenson; George D McSherry; Hannah Gay; Gregory Ciupak; Betsy Smith; James D Connor
Journal:  J Pediatr       Date:  2003-01       Impact factor: 4.406
  10 in total
  9 in total

1.  Canadian consensus guidelines for the management of pregnancy, labour and delivery and for postpartum care in HIV-positive pregnant women and their offspring (summary of 2002 guidelines).

Authors:  David R Burdge; Deborah M Money; John C Forbes; Sharon L Walmsley; Fiona M Smaill; Marc Boucher; Lindy M Samson; Marc Steben
Journal:  CMAJ       Date:  2003-06-24       Impact factor: 8.262

2.  Testing for HIV infection in pregnancy.

Authors: 
Journal:  Paediatr Child Health       Date:  2008-03       Impact factor: 2.253

3.  Intrapartum care of the HIV-positive woman.

Authors:  Kelsey E Mills; Mark H Yudin
Journal:  CMAJ       Date:  2013-10-28       Impact factor: 8.262

4.  Drugs in pregnancy: Implications for a cardiologist.

Authors:  Karel Rakusan
Journal:  Exp Clin Cardiol       Date:  2010

5.  The experience of managing a retroviral antenatal patient in a primary care clinic in Perak, Malaysia.

Authors:  A Subashini; S Malliga; Ar Nooraizam
Journal:  Malays Fam Physician       Date:  2014-04-30

6.  Leukocyte Telomere Length at Birth and During the Early Life of Children Exposed to but Uninfected With HIV After In Utero Exposure to Antiretrovirals.

Authors:  Abhinav Ajaykumar; Hugo Soudeyns; Fatima Kakkar; Jason Brophy; Ari Bitnun; Ariane Alimenti; Arianne Y K Albert; Deborah M Money; Hélène C F Côté
Journal:  J Infect Dis       Date:  2018-02-14       Impact factor: 5.226

7.  The cost-effectiveness of directly observed highly-active antiretroviral therapy in the third trimester in HIV-infected pregnant women.

Authors:  Caitlin J McCabe; Sue J Goldie; David N Fisman
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

8.  Amniocentesis in the HIV-infected pregnant woman: Is there still cause for concern in the era of combination antiretroviral therapy?

Authors:  Nisha Andany; Michelle Letchumanan; Lise Bondy; Kellie Murphy; Mona R Loutfy
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

Review 9.  HIV protease inhibitors in pregnancy : pharmacology and clinical use.

Authors:  Nisha Andany; Mona R Loutfy
Journal:  Drugs       Date:  2013-03       Impact factor: 9.546
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.